Your browser doesn't support javascript.
loading
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label study.
Lv, Huakun; Wang, Shenyu; Liang, Zhenzhen; Yu, Wei; Yan, Chuanfu; Chen, Yingping; Hu, Xiaosong; Fu, Rong; Zheng, Minghuan; Group, Thomas; Luxembourg, Alain; Liao, Xueyan; Chen, Zhiping.
Afiliação
  • Lv H; Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, China. Electronic address: hklv@cdc.zj.cn.
  • Wang S; Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, China. Electronic address: sywang@cdc.zj.cn.
  • Liang Z; Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, China. Electronic address: zzliang@cdc.zj.cn.
  • Yu W; Keqiao District Center for Disease Control and Prevention, Zhejiang, China. Electronic address: 123930980@qq.com.
  • Yan C; Kaihua County Center for Disease Control and Prevention, Zhejiang, China. Electronic address: 379283470@qq.com.
  • Chen Y; Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, China. Electronic address: yingpchen@cdc.zj.cn.
  • Hu X; Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, China. Electronic address: xshu@cdc.zj.cn.
  • Fu R; MSD R&D (China) Co., Ltd., Beijing, China. Electronic address: rong.fu1@merck.com.
  • Zheng M; MSD R&D (China) Co., Ltd., Beijing, China. Electronic address: ming.huan.zheng@merck.com.
  • Group T; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: thomas_group@merck.com.
  • Luxembourg A; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: alain_luxembourg@merck.com.
  • Liao X; MSD R&D (China) Co., Ltd., Beijing, China. Electronic address: xue.yan.liao@merck.com.
  • Chen Z; Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, China. Electronic address: zhpchen@cdc.zj.cn.
Vaccine ; 40(23): 3263-3271, 2022 05 20.
Article em En | MEDLINE | ID: mdl-35487814

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Guideline Limite: Adolescent / Adult / Child / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Guideline Limite: Adolescent / Adult / Child / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article